FDA Approves New Antibiotic for Multiple Bacterial Infections
U.S. Food and Drug Administration
The FDA granted the approval of Zevtera® to Basilea Pharmaceutica International Ltd.
The chip generates results in less than 3.5 hours and helps treat bloodstream infections and sepsis quickly and accurately